Fricke dosimetry for synchrotron stereotactic radiotherapy

Authors

C Boudou, Inserm-U647
M C Biston, Inserm U647
J F Adam, Inserm U647
A Joubert, Inserm U647
s corde, Inserm U647Follow
A M Charvet, Inserm U647
F Esteve, Inserm U647
H Elleaume, Inserm U647

RIS ID

76661

Publication Details

Boudou, C., Biston, M., Adam, J., Joubert, A., corde, s., Charvet, A., Esteve, F. & Elleaume, H. (2004). Fricke dosimetry for synchrotron stereotactic radiotherapy. Journal of Physics : Conference Series, 3 (1), 209-212.

Abstract

In synchrotron stereotactic radiotherapy (SSR) the tumor is loaded with a high Z element, and exposed to monochromatic x-rays from a synchrotron source, in stereotactic conditions. The SSR treatment efficiency is related to the heavy element concentration achievable in the tumor, to the radiation energy, and the irradiation geometry [1,2]. The experimental dose verification of SSR in three dimensions with a good spatial resolution is highly desirable for radiotherapy [3]. In this study, Fricke dosimeter and Monte Carlo calculations were employed for assessing 2D dose distribution.